16 02, 2023

UK retains acceptance of batch testing and EU certification

By |2023-02-16T16:27:10+00:00February 16th, 2023|Featured, General News, General News|

Last year, the UK Department of Health & Social Care issued a statement emphasizing their continued support for the acceptance of batch testing and certification by a Qualified Person (QP) performed in the EU. This statement came after a public consultation seeking opinions on four potential options for a batch testing policy in the UK

20 01, 2023

EMA starts a pilot study to analyze clinical trial raw data

By |2023-01-20T11:10:36+00:00January 20th, 2023|General News|

The European Medicines Agency (EMA) has launched a pilot project to assess the benefits of analyzing raw data from clinical trials by regulatory authorities when evaluating marketing authorization applications (MAAs) for new medicines, as well as post-authorization applications. Raw data constitutes individual patient data from clinical studies in electronic structured format that is directly accessible

4 01, 2023

Amended Labeling Requirements for IMPs

By |2023-01-04T14:51:33+00:00January 4th, 2023|General News|

Following a 1-month feedback period on the draft published in June last year the European Commission (EC) finally adopted on 6 September 2022 the revised Annex VI to Regulation (EU) No 536/2014 (Clinical Trials Regulation, CTR) as regards labelling requirements for IMPs. The Regulation will enter into force on the twentieth day following its publication in the

19 09, 2022

Reminder: 4 days to BREXIT Event!

By |2022-09-19T16:18:13+01:00September 19th, 2022|Featured, General Events, General News|

Our CEO Ann McGee will be speaking at the Pharma and Brexit Conference - hosted by PDA Ireland and PDA United Kingdom. The event will focus on the impact, challenges and solutions for the pharmaceutical industry. Register now on Eventbrite: https://lnkd.in/eVxTutkC Date - September 23rd, 2022 Venue - Crowne Plaza Hotel, Dublin Airport Time - 8:00 a.m. -

14 09, 2022

We Welcome our New CEO Pierre-Henri Baviera

By |2022-10-18T14:54:54+01:00September 14th, 2022|Featured, General Events, General News|

We are very excited to announce the appointment of Pierre-HenriBaviera as the new CEO for Mias Pharma Limited.  As an experienced CEO, Pierre brings significant senior international leadership capabilities in Professional Services and Technology companies. He will be focused on the next phase of growth for MIAS's people and customers in line with our

17 08, 2022

Upcoming Shows

By |2022-08-17T13:42:55+01:00August 17th, 2022|Featured, General Events, General News|

MIAS Pharma will be attending the following events in the coming months: 35th Annual Congress of the European Association of Nuclear Medicine (EANM), Barcelona, 15th - 19th of October 2022. The EANM’s vision is to optimise and advance science and education in nuclear medicine for the benefit of public health and humanity within the

15 12, 2021

Merry Christmas and Happy New Year

By |2021-12-15T16:24:54+00:00December 15th, 2021|Featured, General News|

MIAS has continued exceptional growth and development over 2021. We'd like to thank our Team, Customers and Suppliers for contributing to the continued success of MIAS. We would like to wish you all a very Merry Christmas and we look forward to what will come in 2022. Our offices will close on Friday 24th

Go to Top